Page last updated: 2024-12-06

forphenicinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID68908
CHEMBL ID472562
SCHEMBL ID61390
MeSH IDM0109816

Synonyms (29)

Synonym
72973-11-6
forfenimex
forphenicinol
bf 121
brn 5003730
forfenimexa [spanish]
forfenimex [inn]
(+)-(s)-2-(alpha,3-dihydroxy-p-tolyl)glycine
forfenimexum [latin]
alpha-amino-3-hydroxy-4-(hydroxymethyl)benzeneacetic acid
benzeneacetic acid, alpha-amino-3-hydroxy-4-(hydroxymethyl)-, (s)-
(2s)-2-amino-2-[3-hydroxy-4-(hydroxymethyl)phenyl]acetic acid
CHEMBL472562
AKOS006273975
forfenimexum
unii-el461oy152
71522-58-2
el461oy152 ,
forfenimexa
2-amino-2-[3-hydroxy-4-(hydroxymethyl)phenyl]acetic acid
SCHEMBL61390
forfenimex [jan]
(+)-(s)-2-(.alpha.,3-dihydroxy-p-tolyl)glycine
DTXSID10221764
mfcd22525860
(s)-2-amino-2-(3-hydroxy-4-(hydroxymethyl)phenyl)acetic acid
PS-12007
Q27277225
(s)-2-(3-hydroxy-4-hydroxymethylphenyl)glycine

Research Excerpts

Overview

Fenphenicinol (FPL) is a low molecular immunomodifier derived from forphenicine.

ExcerptReferenceRelevance
"Forphenicinol (FPL) is a low molecular immunomodifier derived from forphenicine, a microbial product found by Umezawa and co-workers. "( Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta, K; Takeuchi, M; Tanaka, T, 1985
)
2.11

Actions

ExcerptReferenceRelevance
"Forphenicinol did not enhance the bactericidal activity of polymorphonuclear cells (PMN) towards P."( Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms.
Arakawa, H; Ishizuka, M; Naito, K; Okura, A; Takeuchi, T; Umezawa, H; Watanabe, Y, 1987
)
1.31

Treatment

Treatment with forphenicinol restored DTH in mice immuno-suppressed by cyclophosphamide. No effect on survival or weight.

ExcerptReferenceRelevance
"The treatment with forphenicinol restored DTH in mice immuno-suppressed by cyclophosphamide to normal response."( Studies on effects of forphenicinol on immune responses.
Aoyagi, T; Ishizeki, S; Ishizuka, M; Masuda, T; Momose, A; Takeuchi, T; Umezawa, H, 1982
)
0.9
"Treatment with forphenicinol had no effect on survival or weight."( Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis.
Hoeprich, PD; Merry, JM, 1987
)
0.92

Compound-Compound Interactions

ExcerptReferenceRelevance
" When combined with surgical resection of primary tumors, forphenicinol administration both before and after resection suppressed the growth of recurrent tumors and prolonged the survival period of the mice."( Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755.
Ishizuka, M; Naito, K; Okura, A; Sawazaki, Y; Takeuchi, T; Umezawa, H, 1986
)
0.84
" These findings suggest that oral administration of FPL in combination with chemotherapeutic agents can be used for treating cancer without causing toxicity, because of the synergistic efficacy of the combination."( Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta, K; Takeuchi, M; Tanaka, T, 1985
)
0.67

Bioavailability

ExcerptReferenceRelevance
" Most of cephalosporin analogs in this series had good antibacterial activities and were well absorbed from the gastrointestinal tract in mice."( Orally absorbable D-forphenicinol-cephalosporins.
Hamada, M; Huang, SP; Ikeda, D; Kondo, S; Koyama, Y; Takeuchi, T, 1989
)
0.6

Dosage Studied

The method is very simple, and sensitive enough to permit the quantification of forphenicinol in the blood samples from man dosed with forphenICinol.

ExcerptRelevanceReference
"1 g) of mice dosed with forphenicine or forphenicinol."( High-performance liquid chromatographic determination of forphenicine in mouse serum and muscle by pre-column fluorescence derivatization using 1,2-diamino-4,5-ethylenedioxybenzene as fluorogenic reagent.
Chao, WF; Kai, M; Ohkura, Y, 1988
)
0.54
" The method is very simple, and sensitive enough to permit the quantification of forphenicinol in the blood samples from man dosed with forphenicinol."( Simple determination of forphenicinol in human plasma and erythrocytes by HPLC with native fluorescence detection.
Kai, M; Ohkura, Y; Ohno, M; Tamura, K, 1986
)
0.8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (94.12)18.7374
1990's0 (0.00)18.2507
2000's2 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.86%)5.53%
Reviews3 (8.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (88.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]